S
301166
vs
S
Shanghai Composite
Over the past 12 months, Shanghai Universal Biotech Co Ltd has underperformed Shanghai Composite, delivering a return of +12% compared to the Shanghai Composite's +22% growth.
Stocks Performance
301166 vs Shanghai Composite
Performance Gap
301166 vs Shanghai Composite
Performance By Year
301166 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai Universal Biotech Co Ltd
Glance View
Shanghai Universal Biotech Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 493 full-time employees. The company went IPO on 2021-12-28. Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The firm is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.
